• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液淀粉样蛋白是从衰老到阿尔茨海默病的整个疾病过程中脑白质高信号的一致预测因子。

CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.

机构信息

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK; Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK; Centre for Medical Image Computing, University College London, London, UK.

出版信息

Neurobiol Aging. 2020 Jul;91:5-14. doi: 10.1016/j.neurobiolaging.2020.03.008. Epub 2020 Mar 17.

DOI:10.1016/j.neurobiolaging.2020.03.008
PMID:32305782
Abstract

This study investigated the relationship between white matter hyperintensities (WMH) and cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. Subjects included 180 controls, 107 individuals with a significant memory concern, 320 individuals with early mild cognitive impairment, 171 individuals with late mild cognitive impairment, and 151 individuals with AD, with 3T MRI and CSF Aβ1-42, total tau (t-tau), and phosphorylated tau (p-tau) data. Multiple linear regression models assessed the relationship between WMH and CSF Aβ1-42, t-tau, and p-tau. Directionally, a higher WMH burden was associated with lower CSF Aβ1-42 within each diagnostic group, with no evidence for a difference in the slope of the association across diagnostic groups (p = 0.4). Pooling all participants, this association was statistically significant after adjustment for t-tau, p-tau, age, diagnostic group, and APOE-ε4 status (p < 0.001). Age was the strongest predictor of WMH (partial R16%) compared with CSF Aβ1-42 (partial R5%). There was no evidence for an association with WMH and either t-tau or p-tau. These data are supportive of a link between amyloid burden and presumed vascular pathology.

摘要

本研究调查了脑白质高信号(WMH)与脑脊液(CSF)阿尔茨海默病(AD)生物标志物之间的关系。受试者包括 180 名对照者、107 名有明显记忆问题者、320 名早期轻度认知障碍者、171 名晚期轻度认知障碍者和 151 名 AD 患者,所有患者均接受了 3T MRI 和 CSF Aβ1-42、总 tau(t-tau)和磷酸化 tau(p-tau)检测。多元线性回归模型评估了 WMH 与 CSF Aβ1-42、t-tau 和 p-tau 之间的关系。在每个诊断组内,WMH 负担越高,CSF Aβ1-42 越低,且 across 诊断组的关联斜率没有差异(p = 0.4)。在调整了 t-tau、p-tau、年龄、诊断组和 APOE-ε4 状态后,pooling 所有参与者,这种关联具有统计学意义(p < 0.001)。与 CSF Aβ1-42(partial R5%)相比,年龄是 WMH 的最强预测因子(partial R16%)。WMH 与 t-tau 或 p-tau 之间没有关联的证据。这些数据支持淀粉样蛋白负荷与假定的血管病理学之间存在联系。

相似文献

1
CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.脑脊液淀粉样蛋白是从衰老到阿尔茨海默病的整个疾病过程中脑白质高信号的一致预测因子。
Neurobiol Aging. 2020 Jul;91:5-14. doi: 10.1016/j.neurobiolaging.2020.03.008. Epub 2020 Mar 17.
2
White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.临床前阿尔茨海默病的脑白质高信号与脑脊液阿尔茨海默病生物标志物。
Neurology. 2020 Mar 3;94(9):e950-e960. doi: 10.1212/WNL.0000000000008864. Epub 2019 Dec 30.
3
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers.脑白质高信号对阿尔茨海默病脑脊液生物标志物无主要混杂作用。
J Alzheimers Dis. 2021;79(1):163-175. doi: 10.3233/JAD-200496.
4
Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.区域脑白质高信号与认知正常和轻度认知障碍老年人的阿尔茨海默病生物标志物。
J Alzheimers Dis. 2023;92(1):323-339. doi: 10.3233/JAD-220846.
5
Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.血管和阿尔茨海默病标志物可独立预测阿尔茨海默病神经影像学倡议对照者的脑萎缩速度。
Neurobiol Aging. 2013 Aug;34(8):1996-2002. doi: 10.1016/j.neurobiolaging.2013.02.003. Epub 2013 Mar 21.
6
White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.轻度认知障碍中的白质高信号与认知衰退风险降低
J Alzheimers Dis. 2015;46(4):855-62. doi: 10.3233/JAD-140618.
7
Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment.种族差异在脑脊液淀粉样蛋白和 tau 生物标志物及相关轻度认知障碍的截断值上的表现。
JAMA Netw Open. 2019 Dec 2;2(12):e1917363. doi: 10.1001/jamanetworkopen.2019.17363.
8
Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.与脑脊液淀粉样蛋白-β1-42 和高血压相关的不同的脑白质改变。
J Alzheimers Dis. 2018;66(3):1095-1104. doi: 10.3233/JAD-180663.
9
Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.阿尔茨海默病脑脊液生物标志物、APOE基因分型与主观认知下降、轻度认知障碍及阿尔茨海默病患者听觉言语学习任务之间的关联
J Alzheimers Dis. 2016 Jul 29;54(1):157-68. doi: 10.3233/JAD-160176.
10
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.

引用本文的文献

1
Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers.与传统的β-淀粉样蛋白和 Tau 蛋白生物标志物相比,评估氧化脂质对阿尔茨海默病连续体认知指标和白质高信号的预测价值。
Mol Neurobiol. 2025 Jul 16. doi: 10.1007/s12035-025-05185-w.
2
White matter fractional anisotropy decreases precede hyperintensities in Alzheimer's disease.在阿尔茨海默病中,白质分数各向异性降低先于高信号出现。
Cell Rep Med. 2025 Jun 17;6(6):102138. doi: 10.1016/j.xcrm.2025.102138. Epub 2025 May 20.
3
Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive Review.
脑淀粉样血管病的血浆生物标志物及其对淀粉样相关影像学异常的影响:综述
J Clin Med. 2025 Feb 7;14(4):1070. doi: 10.3390/jcm14041070.
4
Association of white matter hyperintensities with cognitive decline and neurodegeneration.脑白质高信号与认知衰退及神经退行性变的关联
Front Aging Neurosci. 2024 Sep 12;16:1412735. doi: 10.3389/fnagi.2024.1412735. eCollection 2024.
5
Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis.脑血管成像生物标志物在检测脑淀粉样血管病中的作用。
Alzheimers Dement. 2024 Oct;20(10):7220-7231. doi: 10.1002/alz.14207. Epub 2024 Sep 1.
6
Neuroimaging correlates of Alzheimer's disease biomarker concentrations in a racially diverse high-risk cohort of middle-aged adults.阿尔茨海默病生物标志物浓度在一个种族多样化的中年高危成年人队列中的神经影像学相关性。
Alzheimers Dement. 2024 Sep;20(9):5961-5972. doi: 10.1002/alz.14051. Epub 2024 Aug 13.
7
Characterization of white matter hyperintensities in Down syndrome.唐氏综合征患者脑白质高信号特征分析。
Alzheimers Dement. 2024 Sep;20(9):6527-6541. doi: 10.1002/alz.14146. Epub 2024 Aug 1.
8
Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.将脑白质高信号与阿尔茨海默病的区域性皮质变薄、淀粉样蛋白沉积和突触密度丧失联系起来。
Alzheimers Dement. 2024 Jun;20(6):3931-3942. doi: 10.1002/alz.13845. Epub 2024 Apr 22.
9
Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.脑淀粉样蛋白沉积与脑白质高信号纵向变化的关系。
Alzheimers Res Ther. 2024 Mar 7;16(1):50. doi: 10.1186/s13195-024-01417-8.
10
Genetic Predisposition for White Matter Hyperintensities and Risk of Mild Cognitive Impairment and Alzheimer's Disease: Results from the HELIAD Study.白质高信号的遗传易感性与轻度认知障碍和阿尔茨海默病风险:HELIAD研究结果
Curr Issues Mol Biol. 2024 Jan 22;46(1):934-947. doi: 10.3390/cimb46010060.